Structural Basis for Highly Effective HIV-1 Neutralization by CD4-Mimetic Miniproteins Revealed by 1.5 Å Cocrystal Structure of gp120 and M48U1

被引:28
作者
Acharya, Priyamvada [1 ]
Luongo, Timothy S. [1 ]
Louder, Mark K. [1 ]
McKee, Krisha [1 ]
Yang, Yongping [1 ]
Kwon, Young Do [1 ]
Mascola, John R. [1 ]
Kessler, Pascal [2 ]
Martin, Loic [2 ]
Kwong, Peter D. [1 ]
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] CEA, IBiTecS, Serv Ingn Mol Prot, F-91191 Gif Sur Yvette, France
关键词
IMMUNODEFICIENCY-VIRUS GP120; HUMAN MONOCLONAL-ANTIBODIES; POTENT NEUTRALIZATION; RESISTANCE MUTATIONS; CRYSTAL-STRUCTURES; RATIONAL DESIGN; CD4; ENTRY; BINDING; PROTEIN;
D O I
10.1016/j.str.2013.04.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interface between the HIV-1 gp120 envelope glycoprotein and the CD4 receptor contains an unusual interfacial cavity, the "Phe43 cavity", which CD4-mimetic miniproteins with nonnatural extensions can potentially utilize to enhance their neutralization of HIV-1. Here, we report cocrystal structures of HIV-1 gp120 with miniproteins M48U1 and M48U7, which insert cyclohexylmethoxy and 5-hydroxypentylmethoxy extensions, respectively, into the Phe43 cavity. Both inserts displayed flexibility and hydrophobic interactions, but the M48U1 insert showed better shape complementarity with the Phe43 cavity than the M48U7 insert. Subtle alteration in the gp120 conformation played a substantial role in optimizing fit. With M48U1, these translated into a YU2-gp120 affinity of 0.015 nM and neutralization of all 180 circulating HIV-1 strains tested, except clade-A/E isolates with noncanonical Phe43 cavities. Ligand chemistry, shape complementarity, surface burial, and gp120 conformation act in concert to modulate binding of ligands to the gp120-Phe43 cavity and, when optimized, can effect near-pan-neutralization of HIV-1.
引用
收藏
页码:1018 / 1029
页数:12
相关论文
共 38 条
[1]   Structure-Based Identification and Neutralization Mechanism of Tyrosine Sulfate Mimetics That Inhibit HIV-1 Entry [J].
Acharya, Priyamvada ;
Dogo-Isonagie, Cajetan ;
LaLonde, Judith M. ;
Lam, Son N. ;
Leslie, George J. ;
Louder, Mark K. ;
Frye, Leah L. ;
Debnath, Asim K. ;
Greenwood, Jeremy R. ;
Luongo, Timothy S. ;
Martin, Loic ;
Watts, K. Shawn ;
Hoxie, James A. ;
Mascola, John R. ;
Bewley, Carole A. ;
Kwong, Peter D. .
ACS CHEMICAL BIOLOGY, 2011, 6 (10) :1069-1077
[2]   Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein - Implications for therapeutic and vaccine strategies [J].
Arthos, J ;
Cicala, C ;
Steenbeke, TD ;
Chun, TW ;
Cruz, CD ;
Hanback, DB ;
Khazanie, P ;
Nam, D ;
Schuck, P ;
Selig, SM ;
Van Ryk, D ;
Chaikin, MA ;
Fauci, AS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (13) :11456-11464
[3]   Structure of an unliganded simian immunodeficiency virus gp120 core [J].
Chen, B ;
Vogan, EM ;
Gong, HY ;
Skehel, JJ ;
Wiley, DC ;
Harrison, SC .
NATURE, 2005, 433 (7028) :834-841
[4]   Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120 [J].
Chen, Lei ;
Kwon, Young Do ;
Zhou, Tongqing ;
Wu, Xueling ;
O'Dell, Sijy ;
Cavacini, Lisa ;
Hessell, Ann J. ;
Pancera, Marie ;
Tang, Min ;
Xu, Ling ;
Yang, Zhi-Yong ;
Zhang, Mei-Yun ;
Arthos, James ;
Burton, Dennis R. ;
Dimitrov, Dimiter S. ;
Nabel, Gary J. ;
Posner, Marshall R. ;
Sodroski, Joseph ;
Wyatt, Richard ;
Mascola, John R. ;
Kwong, Peter D. .
SCIENCE, 2009, 326 (5956) :1123-1127
[5]   Enfuvirtide [J].
Chen, RY ;
Kilby, JM ;
Saag, MS .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (12) :1837-1843
[6]   Design, Synthesis, and Antiviral Activity of Entry Inhibitors That Target the CD4-Binding Site of HIV-1 [J].
Curreli, Francesca ;
Choudhury, Spreeha ;
Pyatkin, Ilya ;
Zagorodnikov, Victor P. ;
Bulay, Anna Khulianova ;
Altieri, Andrea ;
Do Kwon, Young ;
Kwong, Peter D. ;
Debnath, Asim K. .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (10) :4764-4775
[7]   MiniCD4 Microbicide Prevents HIV Infection of Human Mucosal Explants and Vaginal Transmission of SHIV162P3 in Cynomolgus Macaques [J].
Dereuddre-Bosquet, Nathalie ;
Morellato-Castillo, Laurence ;
Brouwers, Joachim ;
Augustijns, Patrick ;
Bouchemal, Kawthar ;
Ponchel, Gilles ;
Ramos, Oscar H. P. ;
Herrera, Carolina ;
Stefanidou, Martha ;
Shattock, Robin ;
Heyndrickx, Leo ;
Vanham, Guido ;
Kessler, Pascal ;
Le Grand, Roger ;
Martin, Loic .
PLOS PATHOGENS, 2012, 8 (12)
[8]   Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design [J].
Diskin, Ron ;
Scheid, Johannes F. ;
Marcovecchio, Paola M. ;
West, Anthony P., Jr. ;
Klein, Florian ;
Gao, Han ;
Gnanapragasam, Priyanthi N. P. ;
Abadir, Alexander ;
Seaman, Michael S. ;
Nussenzweig, Michel C. ;
Bjorkman, Pamela J. .
SCIENCE, 2011, 334 (6060) :1289-1293
[9]   Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops [J].
Do Kwon, Young ;
Finzi, Andres ;
Wu, Xueling ;
Dogo-Isonagie, Cajetan ;
Lee, Lawrence K. ;
Moore, Lucas R. ;
Schmidt, Stephen D. ;
Stuckey, Jonathan ;
Yang, Yongping ;
Zhou, Tongqing ;
Zhu, Jiang ;
Vicic, David A. ;
Debnath, Asim K. ;
Shapiro, Lawrence ;
Bewley, Carole A. ;
Mascola, John R. ;
Sodroski, Joseph G. ;
Kwong, Peter D. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (15) :5663-5668
[10]   MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency [J].
Grupping, Katrijn ;
Selhorst, Philippe ;
Michiels, Johan ;
Vereecken, Katleen ;
Heyndrickx, Leo ;
Kessler, Pascal ;
Vanham, Guido ;
Martin, Loic ;
Arien, Kevin K. .
RETROVIROLOGY, 2012, 9